We have a full fledged QCQA department at our Daman Plant & Research & Development department under the guidance of our parent Company M/s Aristo Pharma at Mandideep. The R&D wing & Analytical research & development section is recognized by the department of Science & Technology, Govt. of India.
Marketing efforts of Mapra are supported by a strong Team of highly qualified analytical & formulations Technical experts. Both our plants are equipped with State-of-the-Art technology & equipments facilitating development of conventional & novel drug delivery systems complying to highest standards of quality.
Our capabilities of drug product development are
Immediate release tablets
Enteric coated tablets
Delayed release tablets
Effervescent tablets
Sub-lingual tablets
Mouth dissolving tablets
Chewable tablets
Bi-layered tablets
Extended release tablets
Dry powder for oral suspension
Oral liquid suspension/ syrups
Hard gelatin capsules
Multiple units delayed release/ Extended release tablets (MUPS)
Topical gels, creams, ointments
Powder for injections
Liquid injections
The analytical research & development and QC & QA departments supports all the developmental work of formulation development. We are well equipped with sophisticated instruments capable of stability studies, validation & method or process transfer.
New product development, new process development & ultimate International Quality in offering the best in the clinical application to our end users is our endeavour.
